8-K: Agilent Reports Solid Q1 FY26, Raises Full-Year Outlook

Agilent Technologies delivered solid first-quarter fiscal year 2026 financial results, reporting $1.80 billion in revenue and raising its full-year reported revenue and non-GAAP EPS guidance.

Summary

• First-quarter fiscal year 2026 revenue reached $1.80 billion, marking a 7.0% reported growth and 4.4% core growth compared to Q1 2025.
• GAAP net income for the quarter was $305 million, or $1.07 per share, a 4% decline from the prior year.
• Non-GAAP net income was $386 million, or $1.36 per share, representing a 4% increase year-over-year.
• The company raised its fiscal year 2026 revenue outlook to a range of $7.3 billion to $7.5 billion, reflecting 5.5% to 7.5% reported growth and 4% to 6% core growth.
• Fiscal year 2026 non-GAAP EPS guidance was increased to a range of $5.90 to $6.04.
• Second-quarter fiscal year 2026 revenue is projected between $1.79 billion and $1.82 billion, with non-GAAP EPS expected in the range of $1.39 to $1.42 per share.
• The Life Sciences and Diagnostics Markets Group (LDG) reported $679 million in revenue, with a 16.0% operating margin.
• The Agilent CrossLab Group (ACG) reported $758 million in revenue, achieving a 31.6% operating margin.
• The Applied Markets Group (AMG) reported $361 million in revenue, with a 25.8% operating margin.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, primarily due to the raised full-year guidance and strong non-GAAP performance, despite a slight GAAP decline and weather impact. The underlying business momentum appears solid.

Positives

• Strong reported revenue growth of 7.0% and core revenue growth of 4.4% in Q1 FY26.
• Non-GAAP net income and EPS grew by 4% year-over-year, indicating healthy underlying operational performance.
• Full-year fiscal 2026 reported revenue outlook was raised to $7.3 billion to $7.5 billion.
• Full-year fiscal 2026 non-GAAP EPS guidance was increased to $5.90 to $6.04 per share.
• Management noted that Q1 results would have exceeded the midpoint of guidance on a normalized basis, excluding a major U.S. snowstorm impact.
• Continued momentum in instrument-replacement cycle, strong engagement in Enterprise Services, and innovation across the portfolio.
• Agilent CrossLab Group (ACG) showed robust performance with 9% reported revenue growth and a high operating margin of 31.6%.

Negatives

• GAAP net income declined by 4% to $305 million in Q1 FY26 compared to Q1 FY25.
• GAAP diluted EPS also declined by 4% to $1.07 in Q1 FY26 compared to Q1 FY25.
• Net cash provided by operating activities decreased significantly to $268 million in Q1 FY26 from $431 million in Q1 FY25.
• Net cash used in financing activities increased to $(222) million in Q1 FY26 from $(180) million in Q1 FY25, partly due to higher payments for repurchase of common stock.

Risks

• Unforeseen changes in the strength of Agilent's customers' businesses.
• Unforeseen changes in the demand for current and new products, technologies, and services.
• Unforeseen changes in the currency markets.
• Customer purchasing decisions and timing.
• Risk that Agilent is not able to realize the savings expected from integration and restructuring activities.
• Ability to execute successfully through business cycles.
• Ability to meet and achieve the benefits of its operational transformation, market-focused strategy, and cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions.
• Ongoing competitive, pricing, and gross-margin pressures.
• Risk that cost-cutting initiatives will impair its ability to develop products and remain competitive and to operate effectively.
• The impact of geopolitical uncertainties and global economic conditions on its operations, its markets, and its ability to conduct business.
• The ability to improve asset performance to adapt to changes in demand.
• The impact relating to or arising from changes to tariffs, import/export or trade policies.
• The ability of its supply chain to adapt to changes in demand.
• The ability to successfully introduce new products at the right time, price, and mix.
• The ability of Agilent to successfully integrate recent acquisitions.
• The ability of Agilent to successfully comply with certain complex regulations.

Future Outlook

Agilent Technologies expects full fiscal year 2026 revenue to be in the range of $7.3 billion to $7.5 billion, representing 5.5% to 7.5% reported growth and 4% to 6% core growth. Non-GAAP EPS for the full year is projected between $5.90 and $6.04. For the second fiscal quarter of 2026, revenue is anticipated to be $1.79 billion to $1.82 billion, with non-GAAP EPS in the range of $1.39 to $1.42 per share. The company confirmed its core-revenue growth and margin-expansion outlook for the full year, while modestly increasing its non-GAAP EPS range due to favorable currency.

Management Comments

• "It was a solid start to the year with the Agilent team executing well in a healthy — albeit dynamic — market environment that included navigating the impact of a major U.S. snowstorm during the last week of the quarter." Padraig McDonnell, President and CEO.
• "On a normalized basis, excluding the weather-related impact, first-quarter results would have exceeded the midpoint of our guidance." Padraig McDonnell, President and CEO.
• "This strong underlying performance allows us to maintain our core growth and margin-expansion outlook for the full year, while modestly increasing our non-GAAP EPS range for favorable currency." Padraig McDonnell, President and CEO.
• "The continued momentum in our instrument-replacement cycle, strong engagement in Enterprise Services, and innovation across our portfolio reflect the strength of our customer focused strategy." Padraig McDonnell, President and CEO.
• "With Ignite as our enterprise-wide operating system — driving execution excellence and operational rigor — we are well positioned to deliver resilient growth and long-term value for our customers and shareholders." Padraig McDonnell, President and CEO.

Industry Context

StockSavvy.ai notes that Agilent's performance reflects a resilient demand for analytical and clinical laboratory technologies, despite a 'dynamic' market environment. The company's ability to raise its full-year outlook, particularly non-GAAP EPS, suggests it is effectively navigating industry-specific challenges and leveraging its market position in instrument replacement cycles and enterprise services. This indicates a robust underlying market for life sciences and diagnostics tools, aligning with broader trends of increased R&D and healthcare investment.

Comparison to Industry Standards

• This filing does not provide sufficient specific data points or direct comparisons to named competitors or industry benchmarks to allow for a detailed assessment against global industry standards. The company's core growth rates and operating margins for its segments (LDG 16.0%, ACG 31.6%, AMG 25.8%) would typically be evaluated against peers like Thermo Fisher Scientific, Danaher, or Waters Corporation, but without specific comparative metrics for the same period, a direct assessment is not feasible from this document alone.

Stakeholder Impact

• Shareholders: Positive impact due to raised full-year guidance and strong non-GAAP performance, suggesting potential for continued value creation.
• Employees: Continued focus on "Ignite" as an enterprise-wide operating system implies ongoing operational rigor and potential for efficiency improvements.
• Customers: Continued momentum in instrument-replacement cycle, strong engagement in Enterprise Services, and innovation across the portfolio indicate a focus on meeting customer needs and delivering value.
• Creditors: Stable financial position with $1.758 billion in cash and cash equivalents, and manageable debt levels, suggests low credit risk.

Next Steps

• Agilent's management will present additional details regarding the Q1 2026 financial results on a conference call with investors on February 25, 2026, at 1:30 p.m. PST.
• The replay of the conference call will remain on the company website for 90 days.
• The company will continue to execute its customer-focused strategy, leveraging its Ignite operating system for execution excellence and operational rigor.

Key Dates

Recommendation

The company delivered solid Q1 results, exceeding expectations on a normalized basis despite weather impacts, and importantly, raised its full-year revenue and non-GAAP EPS guidance. This demonstrates strong underlying business momentum, effective management execution, and a positive outlook for core growth and margin expansion. The continued strength in key segments like Agilent CrossLab Group and strategic focus on customer engagement and innovation position the company well for sustained performance, making it an attractive investment.

Keywords

Agilent Technologies, Financial Results, Q1 2026, Earnings, Revenue, EPS, Life Sciences, Diagnostics, Analytical Instruments, Laboratory Technologies, Core Growth, Non-GAAP, Outlook, Guidance